Live Breaking News & Updates on Senti Biosciences Inc

Stay updated with breaking news from Senti biosciences inc. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

2,537,558 Shares in Senti Biosciences, Inc. (NASDAQ:SNTI) Bought by 8Vc Gp I LLC

8Vc Gp I LLC bought a new position in shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Free Report) in the 4th quarter, according to its most recent Form 13F filing with the SEC. The fund bought 2,537,558 shares of the company’s stock, valued at approximately $1,675,000. Senti Biosciences makes up about 1.7% of 8Vc Gp […] ....

Vc Gp , Senti Biosciences Inc , Investment Management , Senti Biosciences , Free Report , Biosciences Stock Down , Get Free Report , Visit Holdingschannel , Senti Biosciences Daily ,

Senti Biosciences (NASDAQ:SNTI) Shares Down 3.5%

Shares of Senti Biosciences, Inc. (NASDAQ:SNTI – Get Free Report) traded down 3.5% during trading on Wednesday . The stock traded as low as $0.36 and last traded at $0.36. 43,559 shares traded hands during mid-day trading, a decline of 64% from the average session volume of 120,647 shares. The stock had previously closed at […] ....

Senti Biosciences Inc , Investment Management , Senti Biosciences Company Profile , Senti Biosciences , Get Free Report , Free Report , Senti Biosciences Daily ,

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the Treatment of Relapsed or Refractory Hematologic Malignancies Including Acute Myeloid Leukemia
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United States , Kanya Rajangam , Securities Exchange , Senti Biosciences Inc , Head Of Research Development , Exchange Commission , Logic Gated , Gene Circuit , Chief Medical Officer , Senti Bio , Gene Circuits , Spark Therapeutics , Securities Act , Securities Exchange Act , Quarterly Report , Senti Biosciences ,

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the ...

Senti Bio Announces First Patient Dosed in Phase 1 Clinical Trial of SENTI-202 for the ...
eagletribune.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from eagletribune.com Daily Mail and Mail on Sunday newspapers.

United States , Kanya Rajangam , Head Of Research Development , Exchange Commission , Senti Biosciences Inc , Securities Exchange , Logic Gated , Gene Circuit , Chief Medical Officer , Senti Bio , Gene Circuits , Spark Therapeutics , Securities Act , Securities Exchange Act , Quarterly Report , Senti Biosciences ,

Contrasting Senti Biosciences (NASDAQ:SNTI) and AlloVir (NASDAQ:ALVR)

Contrasting Senti Biosciences (NASDAQ:SNTI) and AlloVir (NASDAQ:ALVR)
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United States , South San Francisco , Viracyte Inc , Senti Biosciences Inc , Allovir Inc , Celest Therapeutics Shanghai Co , Senti Biosciences , Get Free Report , Given Allovir , Logic Gated , Tumor Associated Antigen , Protective Antigen Paired Discovery Platform , Celest Therapeutics , Senti Biosciences Daily ,